Abstract
Background: There is increasing evidence supporting the Superior Mesenteric Artery (SMA) divestment in pancreatic cancer, especially in the neoadjuvant era. It increases the chances of achieving negative margins, maximizing survival benefits. Vascular variants such as Right Hepatic Artery (RHA) arising from the SMA are quite common and require special care during the final steps of the Whipple to prevent arterial devascularization of the liver.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have